I’m getting excited.
I have closely followed the adoption of state medical cannabis laws and the regulatory environment in the USA over the last 20 years and get the impression that the FDA have historically privileged single molecule drugs such as dronabinol over botanical drug products such as ‘medical cannabis’ in its raw form i.e. cannabis ‘flos’ or botanical extracts comprised of many potentially pharmacologically active compounds. Having said that, it does appear they are becoming more ‘open’ to them: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/botanical-drug-development-guidance-industry
It is my opinion that the FDA would be keen to bring the entire ‘medical marijuana’ industry under its regulatory control but for this to happen I suspect they first require more cannabinoid based medicines approved via their traditional drug approval process.
That is the main reason I bought shares in this company but a successful application to the FDA for this current drug would further bolster my confidence in their ability to navigate the onerous drug approval process.
- Forums
- ASX - By Stock
- BOT
- Bot Chart
Bot Chart, page-7730
-
- There are more pages in this discussion • 7,269 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $671.1M |
Open | High | Low | Value | Volume |
37.0¢ | 39.0¢ | 37.0¢ | $1.232M | 3.263M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
21 | 413183 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.0¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 413183 | 0.370 |
15 | 550628 | 0.365 |
12 | 158045 | 0.360 |
13 | 219306 | 0.355 |
32 | 1342153 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.380 | 50000 | 1 |
0.385 | 182628 | 3 |
0.390 | 154745 | 5 |
0.395 | 221300 | 4 |
0.400 | 157800 | 4 |
Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online